286 related articles for article (PubMed ID: 35085337)
1. Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert® MTB/RIF assay among presumptive tuberculosis cases at Jimma University Medical Center, Southwest Ethiopia.
Admassu W; Ayelign B; Abebe G; Tadesse M
PLoS One; 2022; 17(1):e0262929. PubMed ID: 35085337
[TBL] [Abstract][Full Text] [Related]
2. Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
Raizada N; Sachdeva KS; Nair SA; Kulsange S; Gupta RS; Thakur R; Parmar M; Gray C; Ramachandran R; Vadera B; Ekka S; Dhawan S; Babre A; Ghedia M; Alavadi U; Dewan P; Khetrapal M; Khanna A; Boehme C; Paramsivan CN
PLoS One; 2014; 9(8):e105346. PubMed ID: 25140877
[TBL] [Abstract][Full Text] [Related]
3. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
[TBL] [Abstract][Full Text] [Related]
4. Frequency of MTB and rifampicin resistance MTB using Xpert-MTB/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: A cross sectional study.
Wasihun AG; Dejene TA; Hailu GG
PLoS One; 2020; 15(11):e0240361. PubMed ID: 33147218
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
Mavenyengwa RT; Shaduka E; Maposa I
Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
[TBL] [Abstract][Full Text] [Related]
6. Combination of Xpert® MTB/RIF and DetermineTM TB-LAM Ag improves the diagnosis of extrapulmonary tuberculosis at Jimma University Medical Center, Oromia, Ethiopia.
Simieneh A; Tadesse M; Kebede W; Gashaw M; Abebe G
PLoS One; 2022; 17(2):e0263172. PubMed ID: 35113917
[TBL] [Abstract][Full Text] [Related]
7. Detection of
Diriba G; Alemu A; Tola HH; Eshetu K; Yenew B; Amare M; Dagne B; Mollalign H; Sinshaw W; Abebaw Y; Seid G; Tadesse M; Zerihun B; Getu M; Moga S; Meaza A; Gamtesa DF; Tefera Z; Wondimu A; Hailu M; Buta B; Getahun M; Kebede A
IJID Reg; 2022 Dec; 5():97-103. PubMed ID: 36247095
[TBL] [Abstract][Full Text] [Related]
8. Impact of Xpert MTB/RIF in the Diagnosis of Childhood Tuberculosis in Rural Ethiopia.
Pérez-Butragueño M; Ramos-Rincón JM; Tesfamariam A; Comeche B; Mohammed N; Tiziano G; Endirays J; Biru D; Elala T; Edri A; Prieto L; Górgolas M
J Trop Pediatr; 2022 Jun; 68(4):. PubMed ID: 35848941
[TBL] [Abstract][Full Text] [Related]
9. Trends of Mycobacterium tuberculosis and Rifampicin resistance in Northwest Ethiopia: Xpert® MTB/RIF assay results from 2015 to 2021.
Biset S; Teferi M; Alamirew H; Birhanu B; Dessie A; Aschale A; Haymanot A; Dejenie S; Gebremedhin T; Abebe W; Adane G
BMC Infect Dis; 2024 Feb; 24(1):238. PubMed ID: 38389060
[TBL] [Abstract][Full Text] [Related]
10. Performance of the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed, paraffin-embedded tissues.
Polepole P; Kabwe M; Kasonde M; Tembo J; Shibemba A; O'Grady J; Kapata N; Zumla A; Bates M
Int J Mycobacteriol; 2017; 6(1):87-93. PubMed ID: 28317811
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Xpert MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea.
Kasa Tom S; Welch H; Kilalang C; Tefuarani N; Vince J; Lavu E; Johnson K; Magaye R; Duke T
Paediatr Int Child Health; 2018 May; 38(2):97-105. PubMed ID: 28490246
[TBL] [Abstract][Full Text] [Related]
12. Rifampicin-resistance pattern of Mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients referred to Debre Markos Referral Hospital, Ethiopia: a cross-sectional study.
Mulu W; Abera B; Yimer M; Hailu T; Ayele H; Abate D
BMC Res Notes; 2017 Jan; 10(1):8. PubMed ID: 28057041
[TBL] [Abstract][Full Text] [Related]
13. Rapid detection of Mycobacterium tuberculosis and rifampicin resistance in extrapulmonary tuberculosis and sputum smear-negative pulmonary suspects using Xpert MTB/RIF.
Ullah I; Javaid A; Masud H; Ali M; Basit A; Ahmad W; Younis F; Yasmin R; Khan A; Jabbar A; Husain M; Butt ZA
J Med Microbiol; 2017 Apr; 66(4):412-418. PubMed ID: 28425873
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
Sinshaw W; Kebede A; Bitew A; Tesfaye E; Tadesse M; Mehamed Z; Yenew B; Amare M; Dagne B; Diriba G; Alemu A; Getahun M; Fikadu D; Desta K; Tola HH
BMC Infect Dis; 2019 Jul; 19(1):641. PubMed ID: 31324227
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis.
Elbrolosy AM; El Helbawy RH; Mansour OM; Latif RA
BMC Microbiol; 2021 May; 21(1):144. PubMed ID: 33980173
[TBL] [Abstract][Full Text] [Related]
17. Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia.
Alemu A; Tadesse M; Seid G; Mollalign H; Eshetu K; Sinshaw W; Abebaw Y; Amare M; Dagne B; Diriba G; Yenew B; Getu M; Zerihun B
BMC Infect Dis; 2020 Jan; 20(1):87. PubMed ID: 32000702
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary tuberculosis in an intermediate-prevalence setting].
Ozkutuk N; Surucüoglu S
Mikrobiyol Bul; 2014 Apr; 48(2):223-32. PubMed ID: 24819260
[TBL] [Abstract][Full Text] [Related]
19. Xpert
Kohli M; Schiller I; Dendukuri N; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012768. PubMed ID: 30148542
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of Xpert MTB/RIF assay and non-molecular methods for the diagnosis of tuberculosis lymphadenitis.
Fantahun M; Kebede A; Yenew B; Gemechu T; Mamuye Y; Tadesse M; Brhane B; Jibriel A; Solomon D; Yaregal Z
PLoS One; 2019; 14(9):e0222402. PubMed ID: 31525214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
